Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 1
2016 5
2017 1
2018 1
2019 2
2020 3
2021 12
2022 16
2023 19
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Lifetime Stressful Events Associated with Alzheimer's Pathologies, Neuroinflammation and Brain Structure in a Risk Enriched Cohort.
Palpatzis E, Akinci M, Aguilar-Dominguez P, Garcia-Prat M, Blennow K, Zetterberg H, Carboni M, Kollmorgen G, Wild N, Fauria K, Falcon C, Gispert JD, Suárez-Calvet M, Grau-Rivera O, Sánchez-Benavides G, Arenaza-Urquijo EM; ALFA study. Palpatzis E, et al. Among authors: kollmorgen g. Ann Neurol. 2024 Mar 11. doi: 10.1002/ana.26881. Online ahead of print. Ann Neurol. 2024. PMID: 38466157
Gut inflammation associated with age and Alzheimer's disease pathology: a human cohort study.
Heston MB, Hanslik KL, Zarbock KR, Harding SJ, Davenport-Sis NJ, Kerby RL, Chin N, Sun Y, Hoeft A, Deming Y, Vogt NM, Betthauser TJ, Johnson SC, Asthana S, Kollmorgen G, Suridjan I, Wild N, Zetterberg H, Blennow K, Rey FE, Bendlin BB, Ulland TK. Heston MB, et al. Among authors: kollmorgen g. Sci Rep. 2023 Nov 14;13(1):18924. doi: 10.1038/s41598-023-45929-z. Sci Rep. 2023. PMID: 37963908 Free PMC article.
Associations between recall of proper names in story recall and CSF amyloid and tau in adults without cognitive impairment.
Hale MR, Langhough R, Du L, Hermann BP, Van Hulle CA, Carboni M, Kollmorgen G, Basche KE, Bruno D, Sanson-Miles L, Jonaitis EM, Chin NA, Okonkwo OC, Bendlin BB, Carlsson CM, Zetterberg H, Blennow K, Betthauser TJ, Johnson SC, Mueller KD. Hale MR, et al. Among authors: kollmorgen g. Neurobiol Aging. 2024 Jan;133:87-98. doi: 10.1016/j.neurobiolaging.2023.09.018. Epub 2023 Oct 5. Neurobiol Aging. 2024. PMID: 37925995
Neuroimaging of tissue microstructure as a marker of neurodegeneration in the AT(N) framework: defining abnormal neurodegeneration and improving prediction of clinical status.
Gallagher RL, Koscik RL, Moody JF, Vogt NM, Adluru N, Kecskemeti SR, Van Hulle CA, Chin NA, Asthana S, Kollmorgen G, Suridjan I, Carlsson CM, Johnson SC, Dean DC 3rd, Zetterberg H, Blennow K, Alexander AL, Bendlin BB. Gallagher RL, et al. Among authors: kollmorgen g. Alzheimers Res Ther. 2023 Oct 17;15(1):180. doi: 10.1186/s13195-023-01281-y. Alzheimers Res Ther. 2023. PMID: 37848950 Free PMC article.
CSF metabolites associated with biomarkers of Alzheimer's disease pathology.
Dong R, Lu Q, Kang H, Suridjan I, Kollmorgen G, Wild N, Deming Y, Van Hulle CA, Anderson RM, Zetterberg H, Blennow K, Carlsson CM, Asthana S, Johnson SC, Engelman CD. Dong R, et al. Among authors: kollmorgen g. Front Aging Neurosci. 2023 Aug 30;15:1214932. doi: 10.3389/fnagi.2023.1214932. eCollection 2023. Front Aging Neurosci. 2023. PMID: 37719875 Free PMC article.
Astrocyte biomarkers GFAP and YKL-40 mediate early Alzheimer's disease progression.
Pelkmans W, Shekari M, Brugulat-Serrat A, Sánchez-Benavides G, Minguillón C, Fauria K, Molinuevo JL, Grau-Rivera O, González Escalante A, Kollmorgen G, Carboni M, Ashton NJ, Zetterberg H, Blennow K, Suarez-Calvet M, Gispert JD; ALFA study. Pelkmans W, et al. Among authors: kollmorgen g. Alzheimers Dement. 2024 Jan;20(1):483-493. doi: 10.1002/alz.13450. Epub 2023 Sep 10. Alzheimers Dement. 2024. PMID: 37690071 Free PMC article.
A comparison of diagnostic performance of word-list and story recall tests for biomarker-determined Alzheimer's disease.
Bruno D, Jauregi Zinkunegi A, Kollmorgen G, Carboni M, Wild N, Carlsson C, Bendlin B, Okonkwo O, Chin N, Hermann BP, Asthana S, Blennow K, Langhough R, Johnson SC, Pomara N, Zetterberg H, Mueller KD. Bruno D, et al. Among authors: kollmorgen g. J Clin Exp Neuropsychol. 2023 Oct;45(8):763-769. doi: 10.1080/13803395.2023.2240060. Epub 2023 Aug 12. J Clin Exp Neuropsychol. 2023. PMID: 37571873
Prevalence and Clinical Implications of a β-Amyloid-Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer Disease.
Erickson P, Simrén J, Brum WS, Ennis GE, Kollmorgen G, Suridjan I, Langhough R, Jonaitis EM, Van Hulle CA, Betthauser TJ, Carlsson CM, Asthana S, Ashton NJ, Johnson SC, Shaw LM, Blennow K, Andreasson U, Bendlin BB, Zetterberg H; ADNI Cohort. Erickson P, et al. Among authors: kollmorgen g. JAMA Neurol. 2023 Jul 31;80(9):969-79. doi: 10.1001/jamaneurol.2023.2338. Online ahead of print. JAMA Neurol. 2023. PMID: 37523162 Free PMC article.
Effect of Pathway-Specific Polygenic Risk Scores for Alzheimer's Disease (AD) on Rate of Change in Cognitive Function and AD-Related Biomarkers Among Asymptomatic Individuals.
Xu Y, Vasiljevic E, Deming YK, Jonaitis EM, Koscik RL, Van Hulle CA, Lu Q, Carboni M, Kollmorgen G, Wild N, Carlsson CM, Johnson SC, Zetterberg H, Blennow K, Engelman CD. Xu Y, et al. Among authors: kollmorgen g. J Alzheimers Dis. 2023;94(4):1587-1605. doi: 10.3233/JAD-230097. J Alzheimers Dis. 2023. PMID: 37482996 Free PMC article.
59 results